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Jeffrey Ma, Jeanine Baqai∗
Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, 645 North Michigan Avenue, Suite 440, Chicago, IL, USA
A R T I C L E I N F O
Keywords:
Descemetocele
Alpha-1 antitrypsin deficiency
Corneal patch graft
Corneal tectonic graft
Anterior lamellar keratoplasty
A B S T R A C T
Purpose: To report a case of severe bilateral descemetoceles in a patient with alpha-1 antitrypsin (A1AT) defi-
ciency during intensive care unit hospitalization.
Observations: A 42-year-old male presented with sub-acute bilateral vision loss during an intensive care unit
hospitalization following liver and kidney transplantations. On exam, this patient's best-corrected visual acuity
was 20/80 in both eyes. There were bilateral descemetoceles inferotemporally in both eyes with overlying
epithelial defects and dense surrounding punctate epithelial staining. The patient was initially treated with
gatifloxacin drops and frequent lubricating ointment. Given the concern for impending perforation, cyanoa-
crylate glue with bandage contact lens was applied to both eyes. His best corrected visual acuity remained
unchanged in the right eye and improved to 20/30 in the left eye. Upon medical stabilization, anterior lamellar
graft was performed in the right eye, with plans for the same treatment in the left eye in the future.
Conclusions: As A1AT is found in the tear film and is believed to play a role in regulating protease activity in the
cornea, we hypothesize that this patient's A1AT deficiency exacerbated the progression of corneal ulceration
leading to severe descemetocele formation.
1. Introduction
Alpha-1 antitrypsin (A1AT) deficiency is an inherited disorder in
which impaired production of A1AT, a protease inhibitor, leads to
pulmonary emphysema and liver cirrhosis from unregulated tissue
breakdown and the deposition of abnormal A1AT.1 A1AT is also present
in the tear film and has been shown to regulate proteolytic degradation
within the cornea.2 We present a case of a patient with A1AT deficiency
who developed severe bilateral descemetoceles during intensive care
unit hospitalization.
2. Case report
A 42-year-old male with a history of alpha-1 antitrypsin deficiency,
liver cirrhosis, end-stage renal disease, Moyamoya disease, type 2 dia-
betes mellitus with mild non-proliferative retinopathy, hypertension,
hyperlipidemia, and peripheral vascular disease complained of blurred
vision in both eyes. The ophthalmology service at our tertiary care
hospital was consulted. The patient had undergone a combined liver
and kidney transplantation 2 weeks prior with a complicated post-
operative course in the intensive care unit requiring re-intubation for
respiratory distress and gastrointestinal bleeding. Upon re-extubation 5
days later, he complained of blurred vision and ocular irritation bilat-
erally. On his initial bedside exam, he had best-corrected visual acuities
of 20/80 in both eyes. Slit lamp exam revealed descemetoceles in-
ferotemporally bilaterally measuring about 1.5×1.5 mm in the right
eye and 3.2×2.4 mm in the left eye. There was no overlying epithe-
lium and the epithelial defect extended to the adjacent stroma sur-
rounding the descemetoceles. The anterior chamber was deep and
formed in both eyes. Fundoscopy exam showed mild nonproliferative
diabetic retinopathy.
The patient was medically unstable and limited therapeutic options
were feasible. The patient was initially treated with gatifloxacin drops,
erythromycin ointment, and aggressive lubrication in both eyes.
Cyanoacrylate glue was then applied to both descemetoceles at the
bedside after 5 days and bandage contact lenses were placed. A bedside
tarsorrhaphy was attempted 1 week following initial presentation, but
the patient was unable to tolerate the procedure. The patient was
monitored carefully throughout the remainder of his hospitalization.
Upon discharge, the patient followed up in our clinic. At 1 month
following initial presentation, the glue and contact lenses were absent.
The descemetoceles had re-epithelialized and appeared stable in size,
measuring 1.5×1.5 mm in the right eye and 3.2× 2.4 mm in the left
eye (Fig. 1). Surgical intervention was discussed and planned as soon as
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the transplant team deemed the patient medically optimized. Over the
course of the next several months while the patient slowly recovered
from his transplant surgery and associated complications, his best-
corrected visual acuity remained around 20/80–20/100 in his right eye
and improved to 20/30 in his left eye. Gradually, the descemetocele in
the right eye increased in size to 2.4×2.4 mm, while the descemeto-
cele in the left eye remained stable in size. It is unclear why the right
descemetocele increased in size when the patient's condition appeared
stable. Given the progression in the right eye as well as the patient's
desire to perform surgery in the eye with poorer vision first, surgery in
the right eye was recommended first. Once the patient was cleared for
surgery, a tectonic anterior lamellar keratoplasty was performed in the
right eye, with future plans to perform tectonic keratoplasty in the left
eye (see Fig. 2).
3. Discussion
Alpha-1 antitrypsin is a protease inhibitor that is synthesized by the
liver and serves to protect tissue and oppose digestion of proteins by
enzymes such as neutrophil elastase, collagenase and trypsin. A1AT
deficiency is a hereditary condition that causes abnormal protein
folding and accumulation of A1AT in the liver, resulting in low serum
levels of A1AT and predisposing to liver cirrhosis, pulmonary emphy-
sema, panniculitis and vasculitis.1 In the eye, A1AT has been shown to
be present in the tear film, aqueous humor and cornea, where it plays
an important role in maintaining the structural integrity and transpar-
ency of the cornea by preventing proteolysis of structural proteins, in-
cluding collagen and proteoglycans.2–4 The role of A1AT may be
especially critical in the body's defense against corneal ulceration in
conditions such as infectious keratitis, in which neutrophil elastase and
other enzymes are released by inflammatory mediators and break down
stromal collagen and proteoglycans.5 Interestingly, levels of A1AT are
reduced in the cornea of keratoconus patients, further supporting its
role in maintaining the structural integrity of the cornea and possibly
preventing corneal ectatic disease.6,7
Individuals with A1AT deficiency have also been found to have
decreased A1AT levels in the tear film.8,9 Manners et al. reported a case
of a 5-year-old female with A1AT deficiency that presented with cor-
neal ulceration and scarring after recurrent lower lid styes.8 Here we
report a case of severe bilateral descemetoceles in a critically ill patient
with A1AT deficiency. While critically ill patients can develop corneal
ulceration and descemetoceles, it would be unusual for a patient
without any predisposing factors or exposure to develop such severe,
bilateral descemetoceles. We believe that their development and pro-
gression was mediated by his underlying genetic condition, in which
abnormally low levels of A1AT permitted the unopposed action of
proteolytic enzymes to cause accelerated destruction of the corneal
stromal matrix. It is possible that his 5 days of intubation may have
been associated with exposure keratopathy that contributed to the
disruption of the corneal, although this is uncertain, as he did not have
lagophthalmos upon presentation to our service. The operative and
anesthesia notes from the liver and kidney transplantation were re-
viewed and the eyes were protected and patched during the entire
surgery. Of note, this patient was diagnosed with Moyamoya disease
during this admission after his brain MRI showed marked stenosis and
irregularity of bilateral intracranial internal carotid arteries and bi-
lateral anterior cerebral arteries. While unclear what role, if any, this
may have contributed in the development of his descemetoceles, there
have been reports of carotid artery stenosis leading to corneal and
scleral melts.10,11 Ultimately, multiple underlying factors may have led
to an increased susceptibility to epithelial and stromal degradation in
this patient.
4. Conclusions
Systemic deficiency of alpha-1 antitrypsin, a protease inhibitor,
classically results in liver cirrhosis, pulmonary emphysema and vascu-
litis. This report presents a case of severe bilateral descemetoceles in a
patient with alpha-1 antitrypsin deficiency, highlighting the role of
alpha-1 antitrypsin in regulating and preventing keratolysis and col-
lagen breakdown of the cornea. It is thus advisable that patients with
alpha-1 antitrypsin deficiency receive close ophthalmologic follow-up
for new corneal epithelial defects or ulcers, especially in conditions that
may increase risk of corneal epithelial breakdown such as in exposure
keratopathy during prolonged hospitalizations.
5. Patient consent
Consent to publish the case report was not obtained. This report
does not contain any personal information that could lead to the
identification of the patient.
Funding
No funding or grant support.
Conflicts of interest
The following authors have no financial disclosures: JM, JB.
Authorship
All authors attest that they meet the current ICMJE criteria for
Authorship.
Acknowledgements
We would like to thank Evica Simjanoski and Christina Sammour for
their excellent slit lamp photography. This research has been supported
by Research to Prevent Blindness.
Fig. 1. Slit lamp photographs of the right eye (upper and lower left) and left eye
(upper and lower right) show large descemetoceles at 1 month following initial
presentation.
Fig. 2. Right eye after tectonic keratoplasty.
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Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.ajoc.2019.100513.
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